Morniflumate

Morniflumate (UP 164) is an orally active nonsteroidal anti-inflammatory agent, the β-morpholinoethyl ester of Niflumic acid (HY-B0493) . Morniflumate can be used in the study of inflammatory diseases such as osteoarthritis, painful musculoskeletal disorders and soft tissue inflammation.

Product Specifications

CAS Number

[65847-85-0]

Product Name Alternative

UP 164

UNSPSC

12352005

Hazard Statement

H315-H319-H335

Target

Drug Derivative

Type

Reference compound

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/morniflumate.html

Purity

99.82

Solubility

DMSO : 125 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=CN=C1NC2=CC=CC(C(F)(F)F)=C2)OCCN3CCOCC3

Molecular Formula

C19H20F3N3O3

Molecular Weight

395.38

Precautions

P261-P264-P271-P280-P302+P352-P304+P340-P362+P364-P405-P501

References & Citations

[1]Cremonesi G, et al. Efficacy and safety of morniflumate for the treatment of symptoms associated with soft tissue inflammation. J Int Med Res. 2015 Jun;43 (3) :290-302.|[2]Schiantarelli P, et al. A gastroprotective anti-inflammatory agent: the β-morpholinoethyl ester of niflumic acid (morniflumate) [J]. Agents and Actions, 1984, 14: 247-256.